Developer docs
API playgroundTry for free, no card

Search company profiles

Spectrum Therapeutics, Canopy Growth Germany GmbH

Full company profile

uuid005cxag

Namestring
Spectrum Therapeutics, Canopy Growth Germany GmbH
Legal namestring
Canopy Growth Germany GmbH
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Canopy Growth Germany GmbH is a wholly-owned German subsidiary of Canadian-listed Canopy Growth Corporation, operating under the Canopy Medical and Spectrum Therapeutics brands. The company functions as a pharmaceutical manufacturer, importer, and distributor of medical cannabis products in Germany and positions itself as a leading supplier within the country's regulated medical cannabis supply chain. It sources, processes, and releases dried cannabis flower products with varying THC and CBD concentrations under the German Betäubungsmittelgesetz and international cGMP and cGDP quality standards, and also distributes Storz and Bickel medical vaporizers (VOLCANO medic, MIGHTY medic) under the EU Medical Device Regulation 2017/745.

The core product portfolio comprises medical cannabis flowers marketed under the Canopy Medical brand, the global Tweed sub-brand for trade-event activation, and complementary medical vaporizers sourced from Storz and Bickel GmbH. Go-to-market is exclusively B2B and constrained by German pharmaceutical advertising law: products cannot be promoted directly to patients, so the company operates a DocCheck-verified professional portal for healthcare professionals, a Shopify-powered e-commerce storefront for licensed pharmacies, and supports physicians with prescribing resources, terpene and entourage-effect educational content, and free patient ID cards. The business model is transaction-based B2B pharmaceutical distribution through authenticated online ordering portals with standard 30-day net payment terms (or 3% discount within 30 days), supplied to licensed pharmacies and medical professionals.

The German subsidiary employs approximately six staff based in St. Leon-Rot and is led by Managing Directors Thomas Schaad and Christelle Gedeon. Operating geographies are limited to Germany, with DACH referenced as a broader market label. The entity is registered as Canopy Growth Germany GmbH at the Mannheim court (HRB 722415), with VAT ID DE300590479, and operates with a GDPR-compliant data protection framework (officer: Wojtek Dragon, Project 29 GmbH). The scale of the German operation reflects its role as a regulated import, release, and distribution arm for products manufactured under the parent company's global production footprint.

Short descriptiontext

Pharmaceutical subsidiary of Canopy Growth Corporation operating Canopy Medical and Spectrum Therapeutics brands. Imports, manufactures, and distributes medical cannabis flowers and medical-grade vaporizers to licensed pharmacies and physicians in Germany under BtMG, cGMP, and cGDP standards.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSt. Leon-Rot, Germany
HQ citystring
St. Leon-Rot
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical cannabis, pharmaceutical distribution, cannabis flowers, healthcare professional portal, patient therapy
Industry2 codes
1Medical Cannabis Delivery & Online Ordering
CodeCRANAGAGPrimaryYes
2Cannabis Accessories & Ancillary Product Delivery (Vapes, Papers, Devices)
CodeCRANAGAJPrimaryNo
SIC code1 code
  • Medicinal Chemicals & Botanical Products2833
Product category
Medical Cannabis / Pharmaceutical Distribution
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Medical Cannabis Product Sales
TypeTransaction Fee
Description

B2B sales of medical cannabis flowers and related products to licensed pharmacies and healthcare providers in Germany. Products are sold through an online ordering portal with pharmaceutical-grade distribution standards.

canopymedical.de
2Pharmaceutical Distribution
TypeOne Time License
Description

Sale of medical cannabis products to pharmacies and medical professionals, with payment terms of 30 days net or 3% discount within 30 days. Complies with Good Distribution Practice (cGDP) standards.

canopymedical.de
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1B2B pharmaceutical pricing for pharmacies and medical professionals
ModelTransaction based/ take rateBilling cadenceMonthly
Notes

Pricing available through authenticated professional portal after DocCheck verification. No consumer/public pricing displayed due to regulatory restrictions on pharmaceutical advertising.

canopymedical.de
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Canopy Growth Germany GmbH (Canopy Medical / Spectrum Therapeutics) is a pharmaceutical manufacturer, importer, and distributor of medical cannabis products in Germany. It supplies dried cannabis flowers with varying THC and CBD cannabinoid profiles to licensed pharmacies and, through medical professionals, to patients, and distributes Storz & Bickel medical vaporizer devices, all under cGMP/cGDP and EU MDR pharmaceutical compliance.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Products meet highest medical requirements with continuous testing per international pharmaceutical guidelines
Product overview1 text field

Canopy Growth Germany GmbH (Canopy Medical) operates a multi-brand medical cannabis portfolio consisting of the core Canopy Medical brand offering dried cannabis flower products with varying THC and CBD potencies, the Tweed sub-brand for global market presence, and distribution of Storz & Bickel medical vaporizer devices. The company serves as a pharmaceutical manufacturer, importer, and release agent for medical cannabis products in Germany, operating an e-commerce shop for pharmacies and serving patients through medical professionals. Products are compliant with German pharmaceutical regulations including cGMP and cGDP standards.

Product and service4 records
1Canopy Medical Cannabis Flowers
CategoryMedical Cannabis Flowers
Description

Pharmaceutical-grade dried cannabis flowers marketed under the Canopy Medical brand, offered with varying CBD and THC concentrations and distinct terpene profiles. Sold to licensed German pharmacies for dispensing to patients with valid medical cannabis prescriptions.

2Tweed Medical Cannabis
CategoryMedical Cannabis Brand
Description

Sub-brand of Canopy Growth Corporation offering medical cannabis products in Germany, positioned as a recognizable global cannabis brand for the German medical cannabis market.

3Storz & Bickel Medical Vaporizers (VOLCANO medic, MIGHTY medic)
CategoryMedical Device Distribution
Description

Medical-grade vaporizer devices (including VOLCANO medic and MIGHTY medic) distributed to pharmacies and patients as certified medical devices for inhalation of medical cannabis; Canopy Growth Germany acts as distributor under EU MDR, with Storz & Bickel as the manufacturer.

4Medical Cannabis Professional Portal (Canopy Medical / canopymedical.de)
CategoryB2B Healthcare Professional Services
Description

Restricted-access B2B ordering and information portal for licensed pharmacies and prescribing physicians, enabling pharmacy ordering of medical cannabis flowers and providing prescribing and dispensing resources for healthcare professionals.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierSupportingTypeTechnology or Integration
Description

Storz & Bickel, based in Tuttlingen, Germany, is the manufacturer of medical vaporizer devices (VOLCANO medic, MIGHTY medic) distributed through Canopy Growth Germany. Per MDR regulations, Storz & Bickel is classified as the manufacturer of these medical devices while Canopy Growth and its customers serve as distributors.

Strategic tierSupportingTypeTechnology or Integration
Description

E-commerce platform provider powering the canopymedical.de online store. Data processing occurs on Shopify servers in Ireland, with additional processing by Shopify Inc. entities in Canada and USA under EU standard contractual clauses.

Strategic tierCoreTypeTechnology or Integration
Description

Healthcare professional verification service enabling restricted access to the company's professional portal. DocCheck validates professional credentials (pharmacists, doctors) before granting access to product information and ordering capabilities. Access credentials are managed exclusively by DocCheck servers.

4Rocket Science Group LLC (Mailchimp)
Strategic tierSupportingTypeTechnology or Integration
Description

Email marketing service provider for newsletter campaigns. Processes subscriber data including email addresses on servers in the USA under EU standard contractual clauses. Used for newsletter analytics and campaign management.

canopymedical.de
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Canadian cannabis producer with international medical cannabis ambitions; comparable as another GMP-credentialed supplier targeting European pharmacy channels.

TypeBroad incumbent
Description

Canadian global cannabis producer with European medical operations; comparable as a multi-country medical cannabis supplier with similar GMP/GDP compliant positioning.

TypeDirect peer
Description

German medical cannabis platform and wholesaler connecting pharmacies with producers; competes in the same German pharmacy distribution channel with a marketplace-style model.

TypeBroad incumbent
Description

Global cannabis incumbent with European medical cannabis operations including Germany; comparable as a large multi-jurisdiction medical cannabis producer and distributor targeting the same pharmacy and physician channels.

TypeEmerging player
Description

Cannabis brand focused on premium, pharmaceutical-grade positioning; comparable as a specialized medical/therapeutic-grade cannabis supplier targeting healthcare-adjacent distribution channels.

TypeDirect peer
Description

German medical cannabis producer and distributor headquartered in Germany; directly competes in the same German pharmacy channel with domestically produced medical cannabis flowers.

TypeRegional player
Description

Berlin-based European cannabis company operating across medical and consumer-adjacent categories; comparable as a German-headquartered cannabis operator with medical product distribution.

TypeOthers
Description

German medical vaporizer manufacturer (VOLCANO medic, MIGHTY medic); while not a cannabis producer, it is a critical adjacent partner whose devices are co-distributed by Canopy Growth Germany and serves the same patient population.

TypeDirect peer
Description

German medical cannabis distributor supplying pharmacies with pharmaceutical-grade cannabis products; directly comparable B2B distribution model serving the same German market.

TypeBroad incumbent
Description

International medical cannabis producer with German distribution presence; comparable supply-side position targeting German pharmacies and physicians with pharmaceutical-grade product.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Spectrum Therapeutics, Canopy Growth Germany GmbH

Medical Cannabis / Pharmaceutical Distributionspektrum-cannabis.de

Pharmaceutical subsidiary of Canopy Growth Corporation operating Canopy Medical and Spectrum Therapeutics brands. Imports, manufactures, and distributes medical cannabis flowers and medical-grade vaporizers to licensed pharmacies and physicians in Germany under BtMG, cGMP, and cGDP standards.

What Spectrum Therapeutics, Canopy Growth Germany GmbH does

Canopy Growth Germany GmbH is a wholly-owned German subsidiary of Canadian-listed Canopy Growth Corporation, operating under the Canopy Medical and Spectrum Therapeutics brands. The company functions as a pharmaceutical manufacturer, importer, and distributor of medical cannabis products in Germany and positions itself as a leading supplier within the country's regulated medical cannabis supply chain. It sources, processes, and releases dried cannabis flower products with varying THC and CBD concentrations under the German Betäubungsmittelgesetz and international cGMP and cGDP quality standards, and also distributes Storz and Bickel medical vaporizers (VOLCANO medic, MIGHTY medic) under the EU Medical Device Regulation 2017/745.

The core product portfolio comprises medical cannabis flowers marketed under the Canopy Medical brand, the global Tweed sub-brand for trade-event activation, and complementary medical vaporizers sourced from Storz and Bickel GmbH. Go-to-market is exclusively B2B and constrained by German pharmaceutical advertising law: products cannot be promoted directly to patients, so the company operates a DocCheck-verified professional portal for healthcare professionals, a Shopify-powered e-commerce storefront for licensed pharmacies, and supports physicians with prescribing resources, terpene and entourage-effect educational content, and free patient ID cards. The business model is transaction-based B2B pharmaceutical distribution through authenticated online ordering portals with standard 30-day net payment terms (or 3% discount within 30 days), supplied to licensed pharmacies and medical professionals.

The German subsidiary employs approximately six staff based in St. Leon-Rot and is led by Managing Directors Thomas Schaad and Christelle Gedeon. Operating geographies are limited to Germany, with DACH referenced as a broader market label. The entity is registered as Canopy Growth Germany GmbH at the Mannheim court (HRB 722415), with VAT ID DE300590479, and operates with a GDPR-compliant data protection framework (officer: Wojtek Dragon, Project 29 GmbH). The scale of the German operation reflects its role as a regulated import, release, and distribution arm for products manufactured under the parent company's global production footprint.

Spectrum Therapeutics, Canopy Growth Germany GmbH firmographics

Firmographics
Name
Spectrum Therapeutics, Canopy Growth Germany GmbH
Legal name
Canopy Growth Germany GmbH
Website
https://spektrum-cannabis.de
Company type
Private
Operating status
Operating
Headcount range
1–10 employees
Short description
Pharmaceutical subsidiary of Canopy Growth Corporation operating Canopy Medical and Spectrum Therapeutics brands. Imports, manufactures, and distributes medical cannabis flowers and medical-grade vaporizers to licensed pharmacies and physicians in Germany under BtMG, cGMP, and cGDP standards.
Ownership category
akta.pro rank

Spectrum Therapeutics, Canopy Growth Germany GmbH industry classification

Industry
Product category
Medical Cannabis / Pharmaceutical Distribution
SIC
Medicinal Chemicals & Botanical Products (2833)
akta.pro primary industry
Medical Cannabis Delivery & Online Ordering (CRANAGAG)
akta.pro secondary industry
Cannabis Accessories & Ancillary Product Delivery (Vapes, Papers, Devices) (CRANAGAJ)

Keywords

  • Medical cannabis
  • Pharmaceutical distribution
  • Cannabis flowers
  • Healthcare professional portal
  • Patient therapy

Where Spectrum Therapeutics, Canopy Growth Germany GmbH is headquartered

Location

Headquarters

HQ city
St. Leon-Rot
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

Spectrum Therapeutics, Canopy Growth Germany GmbH business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Medical Cannabis Product Sales: B2B sales of medical cannabis flowers and related products to licensed pharmacies and healthcare providers in Germany. Products are sold through an online ordering portal with pharmaceutical-grade distribution standards.
  2. Pharmaceutical Distribution: Sale of medical cannabis products to pharmacies and medical professionals, with payment terms of 30 days net or 3% discount within 30 days. Complies with Good Distribution Practice (cGDP) standards.

Pricing tiers

ModelBillingPrice
Transaction based/ take rateMonthlyB2B pharmaceutical pricing for pharmacies and medical professionals

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Spectrum Therapeutics, Canopy Growth Germany GmbH product offering

Product offering

Core offering

Canopy Growth Germany GmbH (Canopy Medical / Spectrum Therapeutics) is a pharmaceutical manufacturer, importer, and distributor of medical cannabis products in Germany. It supplies dried cannabis flowers with varying THC and CBD cannabinoid profiles to licensed pharmacies and, through medical professionals, to patients, and distributes Storz & Bickel medical vaporizer devices, all under cGMP/cGDP and EU MDR pharmaceutical compliance.

Product overview

Canopy Growth Germany GmbH (Canopy Medical) operates a multi-brand medical cannabis portfolio consisting of the core Canopy Medical brand offering dried cannabis flower products with varying THC and CBD potencies, the Tweed sub-brand for global market presence, and distribution of Storz & Bickel medical vaporizer devices. The company serves as a pharmaceutical manufacturer, importer, and release agent for medical cannabis products in Germany, operating an e-commerce shop for pharmacies and serving patients through medical professionals. Products are compliant with German pharmaceutical regulations including cGMP and cGDP standards.

Differentiator

Problem solved

Functional benefit

Products and services

  • Canopy Medical Cannabis Flowers Pharmaceutical-grade dried cannabis flowers marketed under the Canopy Medical brand, offered with varying CBD and THC concentrations and distinct terpene profiles. Sold to licensed German pharmacies for dispensing to patients with valid medical cannabis prescriptions.
  • Tweed Medical Cannabis Sub-brand of Canopy Growth Corporation offering medical cannabis products in Germany, positioned as a recognizable global cannabis brand for the German medical cannabis market.
  • Storz & Bickel Medical Vaporizers (VOLCANO medic, MIGHTY medic) Medical-grade vaporizer devices (including VOLCANO medic and MIGHTY medic) distributed to pharmacies and patients as certified medical devices for inhalation of medical cannabis; Canopy Growth Germany acts as distributor under EU MDR, with Storz & Bickel as the manufacturer.
  • Medical Cannabis Professional Portal (Canopy Medical / canopymedical.de) Restricted-access B2B ordering and information portal for licensed pharmacies and prescribing physicians, enabling pharmacy ordering of medical cannabis flowers and providing prescribing and dispensing resources for healthcare professionals.

Quantifiable outcome

  • Products meet highest medical requirements with continuous testing per international pharmaceutical guidelines

Companies that use Spectrum Therapeutics, Canopy Growth Germany GmbH

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Spectrum Therapeutics, Canopy Growth Germany GmbH technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

Feature3 records

Spectrum Therapeutics, Canopy Growth Germany GmbH partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered supporting and core.

  • Storz & Bickel GmbH & Co. KGsupportingTechnology or IntegrationStorz & Bickel, based in Tuttlingen, Germany, is the manufacturer of medical vaporizer devices (VOLCANO medic, MIGHTY medic) distributed through Canopy Growth Germany. Per MDR regulations, Storz & Bickel is classified as the manufacturer of these medical devices while Canopy Growth and its customers serve as distributors.
  • Shopify International LimitedsupportingTechnology or IntegrationE-commerce platform provider powering the canopymedical.de online store. Data processing occurs on Shopify servers in Ireland, with additional processing by Shopify Inc. entities in Canada and USA under EU standard contractual clauses.
  • DocCheck Medical Services GmbHcoreTechnology or IntegrationHealthcare professional verification service enabling restricted access to the company's professional portal. DocCheck validates professional credentials (pharmacists, doctors) before granting access to product information and ordering capabilities. Access credentials are managed exclusively by DocCheck servers.
  • Rocket Science Group LLC (Mailchimp)supportingTechnology or IntegrationEmail marketing service provider for newsletter campaigns. Processes subscriber data including email addresses on servers in the USA under EU standard contractual clauses. Used for newsletter analytics and campaign management.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Spectrum Therapeutics, Canopy Growth Germany GmbH competitors and assessment

Company assessment

Broad incumbents

  • Hexo / Truss Beverage: Canadian cannabis producer with international medical cannabis ambitions; comparable as another GMP-credentialed supplier targeting European pharmacy channels.
  • Aurora Cannabis: Canadian global cannabis producer with European medical operations; comparable as a multi-country medical cannabis supplier with similar GMP/GDP compliant positioning.
  • Tilray: Global cannabis incumbent with European medical cannabis operations including Germany; comparable as a large multi-jurisdiction medical cannabis producer and distributor targeting the same pharmacy and physician channels.
  • Aphria (now part of Tilray): International medical cannabis producer with German distribution presence; comparable supply-side position targeting German pharmacies and physicians with pharmaceutical-grade product.

Direct peers

  • Cansativa: German medical cannabis platform and wholesaler connecting pharmacies with producers; competes in the same German pharmacy distribution channel with a marketplace-style model.
  • Demecan: German medical cannabis producer and distributor headquartered in Germany; directly competes in the same German pharmacy channel with domestically produced medical cannabis flowers.
  • Cannamedical Pharma: German medical cannabis distributor supplying pharmacies with pharmaceutical-grade cannabis products; directly comparable B2B distribution model serving the same German market.

Emerging players

  • FlowKana: Cannabis brand focused on premium, pharmaceutical-grade positioning; comparable as a specialized medical/therapeutic-grade cannabis supplier targeting healthcare-adjacent distribution channels.

Regional players

  • Sanity Group: Berlin-based European cannabis company operating across medical and consumer-adjacent categories; comparable as a German-headquartered cannabis operator with medical product distribution.

Others

  • Storz & Bickel: German medical vaporizer manufacturer (VOLCANO medic, MIGHTY medic); while not a cannabis producer, it is a critical adjacent partner whose devices are co-distributed by Canopy Growth Germany and serves the same patient population.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

Spectrum Therapeutics, Canopy Growth Germany GmbH social profiles

Digital presence

Spectrum Therapeutics, Canopy Growth Germany GmbH compliance and trust

Trust signal

Compliance3 records

Spectrum Therapeutics, Canopy Growth Germany GmbH financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Spectrum Therapeutics, Canopy Growth Germany GmbH leadership team

Management profile

Number of profiles

Profiles2 records

Spectrum Therapeutics, Canopy Growth Germany GmbH funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Spectrum Therapeutics, Canopy Growth Germany GmbH M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Spectrum Therapeutics, Canopy Growth Germany GmbH

What does Spectrum Therapeutics, Canopy Growth Germany GmbH do?

Canopy Growth Germany GmbH (Canopy Medical / Spectrum Therapeutics) is a pharmaceutical manufacturer, importer, and distributor of medical cannabis products in Germany. It supplies dried cannabis flowers with varying THC and CBD cannabinoid profiles to licensed pharmacies and, through medical professionals, to patients, and distributes Storz & Bickel medical vaporizer devices, all under cGMP/cGDP and EU MDR pharmaceutical compliance.

Is Spectrum Therapeutics, Canopy Growth Germany GmbH a public or private company?

Spectrum Therapeutics, Canopy Growth Germany GmbH is a private company. It is classified as corporate owned and is currently operating.

When was Spectrum Therapeutics, Canopy Growth Germany GmbH founded?

Spectrum Therapeutics, Canopy Growth Germany GmbH was founded in -1. It employs 1 to 10 people.

Where is Spectrum Therapeutics, Canopy Growth Germany GmbH based?

Spectrum Therapeutics, Canopy Growth Germany GmbH is headquartered in St. Leon-Rot, Germany, in the Europe region.

How does Spectrum Therapeutics, Canopy Growth Germany GmbH make money?

Two revenue lines are on record. Medical Cannabis Product Sales are the primary driver. The others are pharmaceutical Distribution.

Who are Spectrum Therapeutics, Canopy Growth Germany GmbH's main competitors?

Broad incumbents on record are Hexo / Truss Beverage, Aurora Cannabis, Tilray and Aphria (now part of Tilray). Direct peers are Cansativa, Demecan and Cannamedical Pharma. FlowKana is listed as an emerging player. Sanity Group is listed as a regional player. Storz & Bickel is listed as an others.

Does Spectrum Therapeutics, Canopy Growth Germany GmbH have an API?

No public API is recorded for Spectrum Therapeutics, Canopy Growth Germany GmbH.

What industry is Spectrum Therapeutics, Canopy Growth Germany GmbH in?

Spectrum Therapeutics, Canopy Growth Germany GmbH's product category is Medical Cannabis / Pharmaceutical Distribution. Its primary akta.pro industry code is CRANAGAG, Medical Cannabis Delivery & Online Ordering, with a secondary code of CRANAGAJ, Cannabis Accessories & Ancillary Product Delivery (Vapes, Papers, Devices). Its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Canopy GrowthCanopy Growth and Spectrum Therapeutics Expand Medical Portfolio with New 30 and 90-Pack Softgels and Enhanced Dosing OptionsCanopy Growth Corporation and its subsidiary Spectrum Therapeutics announced on May 7, 2026, an expansion of their Minor Cannabinoid softgel product line, introducing new 30 and 90-pack formats alongside additional dosing options across their Optimized Spectrum portfolio. The expanded range includes daytime formulations such as Clarity CBD:CBG 1:1 and Daily Relief CBD:CBC:CBG variants, as well as nighttime formulations including Unwind CBD:CBN 2:1 and Nighttime Relief CBN:CBD:THC 1:1:2, with products available through Spectrum Therapeutics. The company stated the expansion responds directly to patient and clinic feedback, aiming to improve value, dosing flexibility, affordability, and patient access to minor cannabinoid formulations.Business Wire BlogCanopy Growth and Spectrum Therapeutics Expand Medical Portfolio with New 30 and 90-Pack Softgels and Enhanced Dosing OptionsCanopy Growth and Spectrum Therapeutics expanded their minor cannabinoid softgel portfolio with new 30 and 90-pack formats and additional dosing options. The expansion includes Clarity, Daily Relief, Unwind, and Nighttime Relief formulations, with 90-packs available now and some 30-packs launching in May.Investing.comCanopy Growth repurposes Kelowna facility for medical cannabis By Investing.comCanopy Growth repurposed its Kelowna DOJA facility for exclusive medical cannabis production under Spectrum Therapeutics. The company reported a 75% price return over six months and a 27.83% gross margin. It also completed a $50 million debt prepayment and appointed Tom Stewart as CFO.PharmiWeb.comDermapharm successfully acquires C³ GroupDermapharm Holding SE has completed the acquisition of C³ Cannabinoid Compound Company GmbH, effectively closing the deal on 31 January 2022. The C³ Group, which includes several subsidiaries, was previously owned by Canopy Growth Germany GmbH and generated approximately EUR 40 million in turnover for the financial year 2021. This acquisition positions Dermapharm to expand its market for medical cannabis in Europe, taking advantage of the expected legalization and growing prescriptions of medical cannabis in Germany.PR NewswireSpectrum Therapeutics et Tree of Knowledge annoncent un partenariat ayant comme objectif d'éduquer et de soutenir les professionnels de la santéSpectrum Therapeutics, the medical division of Canopy Growth Corporation, has entered into a two-year partnership with Tree of Knowledge International Corp. to provide education and support for healthcare professionals and patients regarding therapeutic cannabis. The collaboration involves launching online training modules and live webinars through Jack Nathan Health clinics located within Walmart stores across six Canadian provinces. This initiative aims to address knowledge gaps among medical providers and improve patient access to information on pain management and opioid reduction strategies.PR NewswireSpectrum Therapeutics and Tree of Knowledge Announce Partnership to Educate and Support Healthcare ProfessionalsSpectrum Therapeutics, the medical division of Canopy Growth Corporation, has entered into a two-year partnership with Tree of Knowledge International Corp. to provide education and support for healthcare professionals and patients within the Tree of Knowledge network across Canada. The collaboration involves launching e-learning modules and hosting live webinars on medical cannabis best practices through Jack Nathan Health clinics located in Walmart stores. Additionally, the partnership aims to leverage Spectrum Therapeutics' expertise to support the opening of the Mexican medical cannabis market.PR NewswireSpectrum Therapeutics schließt sich der Initiative Not Myself Today® der Canadian Mental Health Association anSpectrum Therapeutics, the medical division of Canopy Growth Corporation, has partnered with the Canadian Mental Health Association (CMHA) to launch an educational module on cannabis use in the workplace under the CMHA's "Not Myself Today" initiative. The collaboration aims to develop digital and physical tools to reduce stigma surrounding cannabinoid-based medicines and promote evidence-based dialogue among employees and healthcare providers. This partnership is part of a broader strategy by Spectrum Therapeutics to address mental health issues through education and research.PR NewswireSpectrum Therapeutics Partners With Canadian Mental Health Association's Not Myself Today® InitiativeSpectrum Therapeutics, the medical division of Canopy Growth Corporation, has partnered with the Canadian Mental Health Association to develop an educational content module on cannabis in the workplace. This initiative, part of the CMHA's Not Myself Today program, aims to reduce stigma and encourage healthcare practitioner oversight regarding medical cannabis use. The module is scheduled for launch early next year and will include digital tools, video resources, and fact sheets.PR NewswireSpectrum Therapeutics partners with Canadian Mental Health Association's Not Myself Today® initiativeSpectrum Therapeutics, the medical division of Canopy Growth Corporation, has announced a partnership with the Canadian Mental Health Association to develop an educational content module on cannabis in the workplace. This initiative is part of CMHA's Not Myself Today program and aims to reduce stigma regarding cannabinoid-based medicines while encouraging healthcare practitioner oversight for patients using cannabis. The module, scheduled to launch early next year, will include digital and physical engagement tools featuring expert video resources and fact sheets.